Companies · Other Health Care

BNVC Group Holdings, Inc.

BOSTON · Other Health Care

Diligence memoA one-page analyst read on BNVC Group Holdings, Inc. — recommendation, valuation, rhythm, risks.
$535.6M
Total raised · real
2
Rounds
1.3×
Latest step-up
Top 1%
Sector rank · raised
Series D+
Latest stage · inferred · Wed Nov 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

BNVC Group Holdings, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.84× the median modeled value of Series D+ Other Health Care companies in 2016–2018 (7 peers) — value vs value, same stage and era.
Dormant
  • Last raise 8.7 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

BNVC Group Holdings, Inc. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
10.0 yr record
Peak capital year was 2017 with $301.1M across 1 filings.
Market position
ahead of 100% of Other Health Care peers
Capital scale is ahead of 100% of Other Health Care peers; modeled value is above 100% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2017: $301.1M across 1 filings.
  • Largest single filing was $301.1M on 2017-11-01.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

BNVC Group Holdings, Inc. is one of 5377 Other Health Care companies tracked from BOSTON. By capital raised it ranks among the largest (ahead of 100% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
18
Investors (latest)
2016
Year incorporated
2017-11-01
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$2.5B$5.0B$7.5B$10.0BSeries D+ · 2016-07-01 Raised $235M (real) Modeled valuation $5.4B (est)$235M$5.4BSeries D+2016Series D+ · 2017-11-01 Raised $301M (real) Modeled valuation $6.9B (est)$301M$6.9BSeries D+2017+$301MCumulative $536M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series D+$234.5M · 2016
Series D+ extension$301.1M · 2017

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B, Series C — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 17%.

Modeled valuation trajectory
$6.9B
Base estimate est.
$1.6B
Conservative case
$15.2B
Upside case
$2.5B
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series D+a $100M–$400M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series D+ · modeled $5.4B · 2016-07-012016Series D+ · modeled $6.9B · 2017-11-012017
Model inputs · modeled:benchmark-stage-stepup-v1
12%
Dilution assumption
Implied ownership sold in the financing.
80%
Survival probability
64% low · 88% high
1.23×/yr
Annual markup
1.38×/yr upside case
6.0 yr
Elapsed time used
8.7 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
16 mo
Avg between rounds
$400.9M/yr
Capital velocity
10.0 yr
On record since
2016
First round
2
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 220× above median
This company$535.6M
Sector median$2.4M
Latest round — vs other Series D+ rounds in sector (real $, this stage) 2.4× above median
This company$301.1M
Sector median$123.0M
Modeled value — vs sector median (estimate, all stages) 314× above median
This company$6.9B
Sector median$22.1M

Raised more than 100% of sector peers (real $). Modeled value above 100% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series D+) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #1 of 7.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0B$100.0B$10.0M$100.0M$1.0BCapital raised (log)Endologix Inc /De/ · Series D+ Raised $420.0M · modeled $4.8B (est)SYFS Intermediate Holdings, LLC · Series D+ Raised $185.5M · modeled $4.3B (est)Allied Integral United, Inc. · Series D+ Raised $164.1M · modeled $3.8B (est)OneOncology Parent Holdings, LLC · Series D+ Raised $103.0M · modeled $2.4B (est)Aeneas Parent Corp. · Series D+ Raised $298.3M · modeled $644.1M (est)Transenterix Inc. · Series D+ Raised $209.9M · modeled $21.9M (est)BNVC Group Holdings, Inc. (this company) Raised $535.6M · modeled $6.9B (est)BNVC Group Holdings, Inc.
CompanyStageRaised · realValue · estvs peer med.
BNVC Group Holdings, Inc. this companySeries D+$535.6M$6.9B1.84×
Endologix Inc /De/Series D+$420.0M$4.8B1.28×
SYFS Intermediate Holdings, LLCSeries D+$185.5M$4.3B1.13×
Allied Integral United, Inc.Series D+$164.1M$3.8B1.00×
OneOncology Parent Holdings, LLCSeries D+$103.0M$2.4B0.63×
Aeneas Parent Corp.Series D+$298.3M$644.1M0.17×
Transenterix Inc.Series D+$209.9M$21.9M0.01×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series D+$234.5M2016-07-01$2.0B$5.4B85%
Series D+$301.1M2017-11-01$2.5B$6.9B90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series D+$234.5M2016-07-01
    • First recorded raise — entered as Series D+.
    • 22 investors on this round.
  2. Series D+$301.1M2017-11-01
    • Raised 16 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 18 investors on this round.
Intelligence
2019 ~Q1
Modeled next raise · ~16mo cadence
$386.7M
Modeled next size est.range $301.1M$618.7M
1.3×
Last step-up
$400.9M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
CHRIS GORDON5 other2016-07
DAVID HUMPHREY5 other2016-07
CHRIS M. SCHREMSER2017-11
CRAIG M. BRIDGE2016-07
JAMES M. DENNY, JR.2016-07
JAMES M. MCDEVITT2016-07
JIM M. LACY2017-11
KEN M. EDWARDS2017-11
KERMIT M. RANDA2017-11
LAURA M. BRIDGE2017-11
MATTHEW M. HAWKINS2017-11
PETER SPRING2016-07
PHIL M. DOLAN2017-11
RIC M. SINCLAIR2017-11
TODD M. WOODS2017-11
WAYNE M. GRODSKEY2017-11
Registry & provenance

BNVC Group Holdings, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1679168
SEC CIK
2016
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Cedar Cares, Inc.Other Health CareSeries D+$569.4M$5.1Bsame sector · same stage
Medable Inc.Other Health CareSeries D+$501.0M$5.4Bsame sector · same stage
Alere Inc.Other Health CareSeries D+$500.0M$9.2Bsame sector · same stage
DispatchHealth Holdings, Inc.Other Health CareSeries D+$578.0M$3.7Bsame sector · same stage
Endologix Inc /De/Other Health CareSeries D+$420.0M$4.8Bsame sector · same stage
Liberty Dialysis Holdings, Inc.Other Health CareSeries D+$688.3M$8.0Bsame sector · same stage
ZAHN Parent, LLCOther Health CareSeries D+$379.9M$8.7Bsame sector · same stage
American Well CorpOther Health CareSeries D+$755.5M$1.1Bsame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
National Cardiac Inc.Other Health CarePre-Seed$17.9M86%
Navierre Holdings, LLCOther Health CareSeed$924K84%
InnovoTEX Inc.Other Health CarePre-Seed$6.6M84%
NorCal Holding Company, Inc.Other Health CareSeries A$100.9M84%
DAV Acquisition Corp.Other Health CarePre-Seed$15.4M83%
BehaVR Holdings, Inc.Other Health CareSeries A$102.1M83%
Navvis & Company, LLCOther Health CareSeries C$1.3B83%
NeuroReserve Inc.Other Health CareSeed$2.4M83%
Frequently asked
How much funding has BNVC Group Holdings, Inc. raised?
BNVC Group Holdings, Inc. has raised approximately $535.6M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is BNVC Group Holdings, Inc.'s estimated valuation?
Provath's modeled valuation for BNVC Group Holdings, Inc. is approximately $6.9B (modeled range $1.6B–$15.2B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is BNVC Group Holdings, Inc. at?
BNVC Group Holdings, Inc.'s latest modeled financing stage is Series D+. Its most recent recorded round closed around Wed Nov 01.
What does BNVC Group Holdings, Inc. do and where is it based?
BNVC Group Holdings, Inc. operates in the Other Health Care sector, based in BOSTON.
Explore related

See where BNVC Group Holdings, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at BNVC Group Holdings, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.